Life Science

Companion Diagnostics for Oncology Market Analysis and Forecast 2021-2028

$ 1,390.00 – $ 5,520.00

Companion Diagnostics for Oncology Market by Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), In situ hybridization (ISH), Fluorescence in situ hybridization (FISH), Others), By Disease Type (Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Leukemia, Melanoma, Others), By End-user (Hospital, Pathology/Diagnostic Laboratory, Academic Medical Center, Others) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

Report Code: EB_LS_1068 | Page: 113 | Published Date: May 2021

Report Published on: May 14, 2021
$ 3,470.00
$ 5,520.00
$ 1,390.00
Clear
Report Code: EBI65515 Categories: ,
Description

The global Companion Diagnostics for Oncology market size is expected to reach $6.18 Billion by 2028 growing at the CAGR of 18.65% from 2021 to 2028. This growth is attributed to several macros and microeconomic factors such as

  • Increase number of cancer test are the driving factor for Companion Diagnostics for Oncology
  • Driver 2

Further several factors restraining the market growth include

  • Restraining 1
  • Restraining 2

Collaborations and Alliances in the Companion Diagnostics for Oncology market are expected to generate higher avenues during the forecast period.

The COVID-19 pandemic has led to supply chain disruptions leading to supply shortages or lower demand in the Companion Diagnostics for Oncology market. The travel restrictions and social-distancing measures have resulted in a sharp drop in consumer and business spending and this pattern is to continue for some time. The end-user trend and preferences have changed due to the pandemic and have resulted in manufacturers, developers, and service providers adopting various strategies to stabilize the company.

 In terms of COVID 19 impact, the Companion Diagnostics for Oncology market report also includes the following data points:

  • Impact on Companion Diagnostics for Oncology market size
  • End-User Trend, Preferences, and Budget Impact
  • Regulatory Framework/Government Policies
  • Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
  • Opportunity in Companion Diagnostics for Oncology market

Key Insight in the report:

The global Companion Diagnostics for Oncology market report covers executive summary, market dynamics, COVID impact & post COVID scenario, market size and forecast, competitive intelligence, market positioning, and product offerings.

Our report covers extensive competitive intelligence which includes the following data points:

  • Business Overview
  • Business Segment Data
  • Financial Data
  • Product Segment Analysis and Specification
  • Recent Development and Company Strategy Analysis
  • SWOT Analysis

The report covers market sizing and forecasting at the country level as well as at the segment level. Companion Diagnostics for Oncology market is analyzed across the below-mentioned different segments:

  • Technology
    • Polymerase Chain Reaction (PCR)
    • Next-Generation Sequencing (NGS)
    • Immunohistochemistry (IHC)
    • In situ hybridization (ISH)
    • Fluorescence in situ hybridization (FISH)
    • Others
  • Disease Type
    • Breast Cancer
    • Non-Small Cell Lung Cancer
    • Colorectal Cancer
    • Leukemia
    • Melanoma
    • Others
  • End-user
    • Hospital
    • Pathology/Diagnostic Laboratory
    • Academic Medical Center
    • Others

 

Companion Diagnostics for Oncology market is also analyzed across the below-mentioned regions/countries:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • Rest of the World
    • South America
    • Middle East & Africa

Some of the key players in Companion Diagnostics for Oncology market include:

  • Agilent Technologies, Inc
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.
  • Hoffmann-La Roche Ltd.
  • ARUP Laboratories
  • Abbott
  • Myriad Genetics, Inc.
  • bioMérieux SA
  • Illumina, Inc.
  • Invivoscribe, Inc.

REPORT CONTENT BRIEF:

  • High-level analysis of the current and future market trends and opportunities
  • Detailed analysis on current market drivers, restraining factors, and opportunities in the future
  • Companion Diagnostics for Oncology market estimates for 2021 and forecast from 2022 to 2028 with CAGR from 2021 to 2028.
  • Vendor market share analysis at each product level
  • Competitor analysis with a detailed insight into its product segment, financial strength, and strategies adopted.
  • Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations, and partnerships as well as funding has taken and investment is done, among others.

Target Audience

  • Manufacturers
  • Suppliers and traders
  • Government, associations, and industrial bodies
  • Investors and trade experts
  • Consulting Firms or Individual Consultant
  • Anyone interested in understanding the industry dynamics of Companion Diagnostics for Oncology market

For more details mail us at

Ask a question / additional requirement

Press Release

Table of Content

Table of Content

Chapter 1.   Executive Summary

 

Chapter 2.   Scope of The Study

                     2.1.   Market Definition

                     2.2.   Scope of The Study

                               2.2.1.   Objectives of Report

 

Chapter 3.   Evolve BI Methodology

 

Chapter 4.   Market Insights and Trends

                     4.1.   Supply/ Value Chain Analysis

                     4.2.   Porter’s Five Forces Analysis

                               4.2.1.   Threat of New Entrants

                               4.2.2.   Bargaining Power of Buyers

                               4.2.3.   Bargaining Power of Suppliers

                               4.2.4.   Threat of Substitutes

                               4.2.5.   Industry Rivalry

                     4.3.   Impact of COVID-19 on Companion Diagnostics for Oncology Market

                               4.3.1.   Impact on Market Size

                               4.3.2.   End User Trend, Preferences and Budget Impact

                               4.3.3.   Regulatory Framework/Government Policies

                               4.3.4.   Key Players Strategy to Tackle Negative Impact

                               4.3.5.   Opportunity Window

 

Chapter 5.   Market Dynamics

                     5.1.   Introduction

                     5.2.   DRO Analysis

                               5.2.1.   Drivers

                               5.2.2.   Restraints

                               5.2.3.   Opportunities

 

Chapter 6.   Global Companion Diagnostics for Oncology Market, By Technology

                     6.1.   Introduction

                     6.2.   Polymerase Chain Reaction (PCR)

                     6.3.   Next-Generation Sequencing (NGS)

                     6.3.   Immunohistochemistry (IHC)

                     6.4.   In situ hybridization (ISH)

                     6.5.   Fluorescence in situ hybridization (FISH)

                     6.6.   Others

 

Chapter 7.   Global Companion Diagnostics for Oncology Market, By Disease Type

                     7.1.   Introduction

                     7.2.   Breast Cancer

                     7.3.   Non-Small Cell Lung Cancer

                     7.4.   Colorectal Cancer

                     7.5.   Leukemia

                     7.6.   Melanoma

                     7.7.   Others

 

Chapter 8.   Global Companion Diagnostics for Oncology Market, By End-user

                     8.1.   Introduction

                     8.2.   Hospital

                     8.3.   Pathology/Diagnostic Laboratory

                     8.4.   Academic Medical Center

                     8.5.   Others

 

Chapter 9.   Global Companion Diagnostics for Oncology Market, By Region

                     9.1.   Introduction

                     9.2.   North America

                               9.2.1.   Introduction

                               9.2.2.   Driving Factors, Opportunity Analyzed and Key Trends

                               9.2.3.   Market Size and Forecast, By Country, 2020 - 2028

                               9.2.4.   Market Size and Forecast, By Technology, 2020 - 2028

                               9.2.5.   Market Size and Forecast, By Disease Type, 2020 – 2028

                               9.2.6.   Market Size and Forecast, By End-user, 2020 – 2028

                               9.2.7.   US

                                              9.2.7.1.   Introduction

                                              9.2.7.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.2.7.3.   Market Size and Forecast, By Technology, 2020 - 2028

                                              9.2.7.4.   Market Size and Forecast, By Disease Type, 2020 – 2028

                                              9.2.7.5.   Market Size and Forecast, By End-user, 2020 - 2028

                               9.2.8.   Canada

                                              9.2.8.1.   Introduction

                                              9.2.8.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.2.8.4.   Market Size and Forecast, By Technology, 2020 - 2028

                                              9.2.8.5.   Market Size and Forecast, By Disease Type, 2020 – 2028

                                              9.2.8.6.   Market Size and Forecast, By End-user, 2020 - 2028

                     9.3.   Europe

                               9.3.1.   Introduction

                               9.3.2.   Driving Factors, Opportunity Analyzed and Key Trends

                               9.3.3.   Market Size and Forecast, By Country, 2020 - 2028

                               9.3.4.   Market Size and Forecast, By Technology, 2020 - 2028

                               9.3.5.   Market Size and Forecast, By Disease Type, 2020 – 2028

                               9.3.6.   Market Size and Forecast, By End-user, 2020 – 2028

                               9.3.7.   Germany

                                              9.3.7.1.   Introduction

                                              9.3.7.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.3.7.3.   Market Size and Forecast, By Technology, 2020 - 2028

                                              9.3.7.4.   Market Size and Forecast, By Disease Type, 2020 – 2028

                                              9.3.7.5.   Market Size and Forecast, By End-user, 2020 - 2028

                               9.3.8.   France

                                              9.3.8.1.   Introduction

                                              9.3.8.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.3.8.3.   Market Size and Forecast, By Technology, 2020 - 2028

                                              9.3.8.4.   Market Size and Forecast, By Disease Type, 2020 – 2028

                                              9.3.8.5.   Market Size and Forecast, By End-user, 2020 - 2028

                               9.3.9.   UK

                                              9.3.9.1.   Introduction

                                              9.3.9.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.3.9.3.   Market Size and Forecast, By Technology, 2020 - 2028

                                              9.3.9.4.   Market Size and Forecast, By Disease Type, 2020 – 2028

                                              9.3.9.5.   Market Size and Forecast, By End-user, 2020 - 2028

                               9.3.10.   Italy

                                              9.3.10.1.   Introduction

                                              9.3.10.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.3.10.3.   Market Size and Forecast, By Technology, 2020 - 2028

                                              9.3.10.4.   Market Size and Forecast, By Disease Type, 2020 – 2028

                                              9.3.10.5.   Market Size and Forecast, By End-user, 2020 - 2028

                               9.3.11.   Rest of Europe

                                              9.3.11.1.   Introduction

                                              9.3.11.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.3.11.3.   Market Size and Forecast, By Technology, 2020 - 2028

                                              9.3.11.4.   Market Size and Forecast, By Disease Type, 2020 – 2028

                                              9.3.11.5.   Market Size and Forecast, By End-user, 2020 - 2028

                     9.4.   Asia-Pacific

                               9.4.1.   Introduction

                               9.4.2.   Driving Factors, Opportunity Analyzed and Key Trends

                               9.4.3.   Market Size and Forecast, By Country, 2020 - 2028

                               9.4.4.   Market Size and Forecast, By Technology, 2020 - 2028

                               9.4.5.   Market Size and Forecast, By Disease Type, 2020 – 2028

                               9.4.7.   Market Size and Forecast, By End-user, 2020 - 2028

                               9.4.8.   China

                                              9.4.8.1.   Introduction

                                              9.4.8.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.4.8.3.   Market Size and Forecast, By Technology, 2020 - 2028

                                              9.4.8.4.   Market Size and Forecast, By Disease Type, 2020 – 2028

                                              9.4.8.5.   Market Size and Forecast, By End-user, 2020 - 2028

                               9.4.9.   India

                                              9.4.9.1.   Introduction

                                              9.4.9.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.4.9.3.   Market Size and Forecast, By Technology, 2020 - 2028

                                              9.4.9.4.   Market Size and Forecast, By Disease Type, 2020 – 2028

                                              9.4.9.5.   Market Size and Forecast, By End-user, 2020 - 2028

                               9.4.10.   Japan

                                              9.4.10.1.   Introduction

                                              9.4.10.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.4.10.3.   Market Size and Forecast, By Technology, 2020 - 2028

                                              9.4.10.4.   Market Size and Forecast, By Disease Type, 2020 – 2028

                                              9.4.10.5.   Market Size and Forecast, By End-user, 2020 - 2028

                               9.4.11.   South Korea

                                              9.4.11.1.   Introduction

                                              9.4.11.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.4.11.3.   Market Size and Forecast, By Technology, 2020 - 2028

                                              9.4.11.4.   Market Size and Forecast, By Disease Type, 2020 – 2028

                                              9.4.11.5.   Market Size and Forecast, By End-user, 2020 - 2028

                               9.4.12.   Rest of Asia-Pacific

                                              9.4.11.1.   Introduction

                                              9.4.12.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.4.12.3.   Market Size and Forecast, By Technology, 2020 - 2028

                                              9.4.12.4.   Market Size and Forecast, By Disease Type, 2020 – 2028

                                              9.4.12.5.   Market Size and Forecast, By End-user, 2020 - 2028

                     9.5.   Rest of The World (RoW)

                               9.5.1.   Introduction

                               9.5.2.   Driving Factors, Opportunity Analyzed and Key Trends

                               9.5.3.   Market Size and Forecast, By Technology, 2020 - 2028

                               9.5.4.   Market Size and Forecast, By Disease Type, 2020 – 2028

                               9.5.5.   Market Size and Forecast, By End-user, 2020 - 2028

                               9.5.6.   Market Size and Forecast, By Region, 2020 - 2028

                               9.5.7.   South America

                                              9.5.7.1.   Introduction

                                              9.5.7.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.5.7.3.   Market Size and Forecast, By Technology, 2020 - 2028

                                              9.5.7.4.   Market Size and Forecast, By Disease Type, 2020 – 2028

                                              9.5.7.5.   Market Size and Forecast, By End-user, 2020 - 2028

                               9.5.8.   Middle East & Africa

                                              9.5.8.1.   Introduction

                                              9.5.8.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.5.8.3.   Market Size and Forecast, By Technology, 2020 - 2028

                                              9.5.8.4.   Market Size and Forecast, By Disease Type, 2020 – 2028

                                              9.5.8.5.   Market Size and Forecast, By End-user, 2020 - 2028

 

Chapter 10.   Competitive Landscape

                     10.1.   Introduction

                     10.2.   Vendor Share Analysis, 2020/Key Players Positioning 2020

 

Chapter 11.   Company Profiles

                     11.1.   Agilent Technologies, Inc

                               11.1.1.   Business Overview

                               11.1.2.   Financial Analysis

                               11.1.3.   Product Portfolio

                               11.1.4.   Recent Development and Strategies Adopted

                               11.1.5.   SWOT Analysis

                     11.2.   QIAGEN N.V.

                               11.2.1.   Business Overview

                               11.2.2.   Financial Analysis

                               11.2.3.   Product Portfolio

                               11.2.4.   Recent Development and Strategies Adopted

                               11.2.5.   SWOT Analysis

                     11.3.   Thermo Fisher Scientific, Inc.

                               11.3.1.   Business Overview

                               11.3.2.   Financial Analysis

                               11.3.3.   Product Portfolio

                               11.3.4.   Recent Development and Strategies Adopted

                               11.3.5.   SWOT Analysis

                     11.4.   F. Hoffmann-La Roche Ltd.

                               11.4.1.   Business Overview

                               11.4.2.   Financial Analysis

                               11.4.3.   Product Portfolio

                               11.4.4.   Recent Development and Strategies Adopted

                               11.4.5.   SWOT Analysis

                     11.5.   ARUP Laboratories

                               11.5.1.   Business Overview

                               11.5.2.   Financial Analysis

                               11.5.3.   Product Portfolio

                               11.5.4.   Recent Development and Strategies Adopted

                               11.5.5.   SWOT Analysis

                     11.6.   Abbott

                               11.6.1.   Business Overview

                               11.6.2.   Financial Analysis

                               11.6.3.   Product Portfolio

                               11.6.4.   Recent Development and Strategies Adopted

                               11.6.5.   SWOT Analysis

                     11.7.   Myriad Genetics, Inc.

                               11.7.1.   Business Overview

                               11.7.2.   Financial Analysis

                               11.7.3.   Product Portfolio

                               11.7.4.   Recent Development and Strategies Adopted

                               11.7.5.   SWOT Analysis

                     11.8.   bioMérieux SA

                               11.8.1.   Business Overview

                               11.8.2.   Financial Analysis

                               11.8.3.   Product Portfolio

                               11.8.4.   Recent Development and Strategies Adopted

                               11.8.5.   SWOT Analysis

                     11.9.   Illumina, Inc.

                               11.9.1.   Business Overview

                               11.9.2.   Financial Analysis

                               11.9.3.   Product Portfolio

                               11.9.4.   Recent Development and Strategies Adopted

                               11.9.5.   SWOT Analysis

                     11.10.   Invivoscribe, Inc.

                               11.10.1.   Business Overview

                               11.10.2.   Financial Analysis

                               11.10.3.   Product Portfolio

                               11.9.4.   Recent Development and Strategies Adopted

                               11.9.5.   SWOT Analysis

 

Chapter 12.   Key Takeaways

Connect to Analyst

Connect to Analyst

Research Methodology

Research Methodology

Our Most Viewed Report and gain instant expertise

Life Science
$ 3,470.00
$ 5,520.00
$ 1,390.00
Clear

Blood Purification Equipment Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00
Blood Purification Equipment Market Research Report: By Product Type (Portable, Stationary), By Indication (Sepsis, Renal Diseases, Others), By End User (Hospitals and Clinics, Dialysis Centers, Others), and by Region — Forecast till 2033 Page: 165
Select options This product has multiple variants. The options may be chosen on the product page
Quick view
Healthcare
$ 3,470.00
$ 5,520.00
$ 1,390.00
Clear

Gene Therapy Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00
Gene Therapy Market Research Report: Information By Therapy Type (Somatic, Germline), By Vector Type (Non-Viral Vectors, Viral Vectors), By Application (Cancer Diseases, Monogenic Diseases, Infectious Diseases, Cardiovascular Diseases, Others), and by Region — Forecast till 2033
Select options This product has multiple variants. The options may be chosen on the product page
Quick view
Healthcare
$ 3,470.00
$ 5,520.00
$ 1,390.00
Clear

Heart Transplantation Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00
Heart Transplantation Market Research Report: Information By Surgery Type (Total Artificial Heart, Biventricular Pacing, Heart Restraint Devices, Ventricular Assist Devices, Other), By End Use (Hospitals, Cardiac institutes, Research Centers, Laboratories, Other), and by Region — Forecast till 2033
Select options This product has multiple variants. The options may be chosen on the product page
Quick view
Life Science
$ 3,470.00
$ 5,520.00
$ 1,390.00
Clear

Pain Management Drugs Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00
Pain Management Drugs Market Research Report: Information By Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Others), By Indication (Arthritic Pain, Neuropathic Pain, Others), and by Region — Forecast till 2033 Page: 157
Select options This product has multiple variants. The options may be chosen on the product page
Quick view
Life Science
$ 3,470.00
$ 5,520.00
$ 1,390.00
Clear

Particle Counters Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00
Particle Counters Market Research Report: Information By Product Type (Cleanroom Monitoring, Drinking Water Contamination Monitoring, Aerosol Monitoring and Research, Others), By Application (Airborne Particle Counters, Liquid Particle Counters), and by Region — Forecast till 2033 Page: 169
Select options This product has multiple variants. The options may be chosen on the product page
Quick view
Life Science
$ 3,470.00
$ 5,520.00
$ 1,390.00
Clear

Proteomics Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00
Proteomics Market Research Report: Information By Component (Instruments, Reagents, Services), By Application (Drug Discovery, Diseases Diagnosis), and by Region — Forecast till 2033 Page: 162
Select options This product has multiple variants. The options may be chosen on the product page
Quick view
Life Science
$ 3,470.00
$ 5,520.00
$ 1,390.00
Clear

Telmisartan Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00

Telmisartan Market Research Report: Information By Indication (Hypertension and Cardiovascular Risk Reduction), By Sales Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies), and by Region — Forecast till 2033

Page: 164
Select options This product has multiple variants. The options may be chosen on the product page
Quick view
Life Science
$ 3,470.00
$ 5,520.00
$ 1,390.00
Clear

Vaccine Market Analysis and Global Forecast 2023-2033

$ 1,390.00 – $ 5,520.00

Vaccine Market Research Report: Information By Type (Monovalent Vaccines, Multivalent Vaccines), By Indication (Pneumococcal Diseases, DTP, HPV, Influenza, Meningococcal Disease, Polio, Hepatitis, Rotavirus, MMR, Varicella, Herpes Zoster, Ebola, COVID, Others), By Application (Conjugate Vaccines, Inactivated & Subunit, Live Attenuated, Recombinant Vaccines), and by Region — Forecast till 2033

Report Code: EB_LS_450 | Page: 219
Select options This product has multiple variants. The options may be chosen on the product page
Quick view